Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 277

1.

Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity.

Hanaoka H, Okazaki Y, Satoh T, Kaneko Y, Yasuoka H, Seta N, Kuwana M.

Lupus. 2012 Oct;21(12):1284-93. Epub 2012 Jun 27.

PMID:
22740429
2.

Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.

Julkunen H, Ekblom-Kullberg S, Miettinen A.

Rheumatol Int. 2012 Aug;32(8):2445-51. doi: 10.1007/s00296-011-1962-3. Epub 2011 Jun 26.

PMID:
21706294
3.

Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.

Eivazova ER, McDonnell JM, Sutton BJ, Staines NA.

Arthritis Rheum. 2000 Feb;43(2):429-39.

4.

Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.

Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.

Clin Rheumatol. 2003 Oct;22(4-5):271-8.

PMID:
14576989
5.

Clinical disease activity and titers of anti-dsDNA antibodies measured by an automated immunofluorescence assay in patients with systemic lupus erythematosus.

López-Hoyos M, Cabeza R, Martínez-Taboada VM, Crespo J, SanSegundo D, Blanco R, López-Escribano H, Peña M, Rodríguez-Valverde V.

Lupus. 2005;14(7):505-9.

PMID:
16130504
6.
7.

Prior anti-dsDNA antibody status does not predict later disease manifestations in systemic lupus erythematosus.

van den Berg L, Nossent H, Rekvig O.

Clin Rheumatol. 2006 May;25(3):347-52. Epub 2005 Nov 23.

PMID:
16328091
8.
9.

Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.

Suleiman S, Kamaliah D, Nadeem A, Naing NN, Che Maraina CH.

Int J Rheum Dis. 2009 Jul;12(2):100-6. doi: 10.1111/j.1756-185X.2009.01391.x.

PMID:
20374326
10.
11.

Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity.

Andrejevic S, Jeremic I, Sefik-Bukilica M, Nikolic M, Stojimirovic B, Bonaci-Nikolic B.

Clin Rheumatol. 2013 Nov;32(11):1619-26. doi: 10.1007/s10067-013-2330-3. Epub 2013 Jul 16.

PMID:
23857662
12.

Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.

Saigal R, Goyal LK, Agrawal A, Mehta A, Mittal P, Yadav RN, Meena PD, Wadhvani D.

J Assoc Physicians India. 2013 Jun;61(6):372-7.

PMID:
24640201
13.

Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.

Pradhan VD, Patwardhan MM, Ghosh K.

Indian J Dermatol Venereol Leprol. 2010 Mar-Apr;76(2):145-9. doi: 10.4103/0378-6323.60558.

14.

The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation.

Bootsma H, Spronk PE, Ter Borg EJ, Hummel EJ, de Boer G, Limburg PC, Kallenberg CG.

Ann Rheum Dis. 1997 Nov;56(11):661-6.

15.

Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.

Williams RC Jr, Malone CC, Meyers C, Decker P, Muller S.

J Rheumatol. 2001 Jan;28(1):81-94.

PMID:
11196548
16.

Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.

Zhao Z, Weinstein E, Tuzova M, Davidson A, Mundel P, Marambio P, Putterman C.

Arthritis Rheum. 2005 Feb;52(2):522-30.

17.

Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring.

Villalta D, Romelli PB, Savina C, Bizzaro N, Tozzoli R, Tonutti E, Ghirardello A, Doria A.

Lupus. 2003;12(1):31-6.

PMID:
12587824
18.

High frequency of Smith autoantibodies in Omani patients with systemic lupus erythematosus.

Al-Jabri AA, Al-Gahdani AK, Al-Shuaili I.

Rheumatol Int. 2009 Nov;30(1):51-6. doi: 10.1007/s00296-009-0909-4.

PMID:
19360411
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk